Skip to content

A clinical study to evaluate the effects of Vasadi Kwath and Nitya virechan Karma in patients with uncomplicated tamak swasa(Bronchial asthma)

Clinical evaluation of Vasadi kwath and Nitya virechan Karma in the management of uncomplicated tamak swasa (Bronchial asthma) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059879
Enrollment
60
Registered
2023-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr Motiur Rahman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The patients will be above 20 years and below 70 years of age. 2.Both sex will be included on the basis of signs & symptoms of bronchial asthma irrespective of cast and religion.

Exclusion criteria

Exclusion criteria: 1.Patients with the history of pulmonary tuberculosis,pleural effusion,Cardiac Asthma, emphysema, bronchial carcinoma, status asthmatics will be excluded from the trial. 2.Child below 20 years. 3.Older people above 70 years. 4.Pregnant women & lactating mother.

Design outcomes

Primary

MeasureTime frame
To study the comparative effect of Vasadi kwath and Nitya Virechana Karma. Timepoint: 15 days

Secondary

MeasureTime frame
To study pathophysiology & clinical evaluation of Tamaka Shwasa Timepoint: 15,30,45,60 days

Countries

India

Contacts

Public ContactDr Shyamanta Kalita

Government Ayurvedic College and Hospital, Jalukbari, Guwahati

rmotiur549@gmail.com9101355164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026